{"id":"https://openalex.org/W2016981968","doi":"https://doi.org/10.1016/j.jnci.2015.01.004","title":"Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening","display_name":"Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening","alternate_titles":[],"publication_year":2015,"publication_date":"2015-02-21","ids":{"openalex":"https://openalex.org/W2016981968","doi":"https://doi.org/10.1016/j.jnci.2015.01.004","mag":"2016981968","pmid":"https://pubmed.ncbi.nlm.nih.gov/25716703"},"language":"en","primary_location":{"id":"doi:10.1016/j.jnci.2015.01.004","doi":"https://doi.org/10.1016/j.jnci.2015.01.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jnci.2015.01.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1110036215000060/pdf","source":{"id":"https://openalex.org/S4210209315","display_name":"Journal of the Egyptian National Cancer Institute","issn_l":"1110-0362","issn":["1110-0362","2589-0409"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Egyptian National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016981968"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S1110036215000060/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063099905","display_name":"Tamer Abd Elhamid Elbedewy","orcid":"https://orcid.org/0000-0003-4376-1873","observed_orcids":["https://orcid.org/0000-0003-4376-1873"]},"institutions":[{"id":"https://openalex.org/I21376657","display_name":"Tanta University","ror":"https://ror.org/016jp5b92","country_code":"EG","type":"education","lineage":["https://openalex.org/I21376657"]}],"countries":["EG"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tamer A. Elbedewy","raw_affiliation_strings":["Internal Medicine Department, Faculty of Medicine, Tanta University, Egypt. Electronic address: tamerelbedewy2006@yahoo.com","Internal Medicine Department, Faculty of Medicine, Tanta University, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine Department, Faculty of Medicine, Tanta University, Egypt. Electronic address: tamerelbedewy2006@yahoo.com","institution_ids":["https://openalex.org/I21376657"]},{"raw_affiliation_string":"Internal Medicine Department, Faculty of Medicine, Tanta University, Egypt","institution_ids":["https://openalex.org/I21376657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084371882","display_name":"Hossam Eldin A. Elashtokhy","orcid":"https://orcid.org/0009-0008-3557-7738","observed_orcids":["https://orcid.org/0009-0008-3557-7738","https://orcid.org/0000-0003-3134-8117"]},"institutions":[{"id":"https://openalex.org/I4405279817","display_name":"Tanta Cancer Center","ror":"https://ror.org/0221r9r57","country_code":"EG","type":"healthcare","lineage":["https://openalex.org/I4210160667","https://openalex.org/I4405279817"]}],"countries":["EG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hossam Eldin A. Elashtokhy","raw_affiliation_strings":["Medical Oncology Department, Tanta Cancer Center, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Tanta Cancer Center, Egypt","institution_ids":["https://openalex.org/I4405279817"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113890202","display_name":"Enaam Rabee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21376657","display_name":"Tanta University","ror":"https://ror.org/016jp5b92","country_code":"EG","type":"education","lineage":["https://openalex.org/I21376657"]}],"countries":["EG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Enaam S. Rabee","raw_affiliation_strings":["Clinical Pathology Department, Faculty of Medicine, Tanta University, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pathology Department, Faculty of Medicine, Tanta University, Egypt","institution_ids":["https://openalex.org/I21376657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025546285","display_name":"Gamal E. Kheder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405279817","display_name":"Tanta Cancer Center","ror":"https://ror.org/0221r9r57","country_code":"EG","type":"healthcare","lineage":["https://openalex.org/I4210160667","https://openalex.org/I4405279817"]}],"countries":["EG"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gamal E. Kheder","raw_affiliation_strings":["Clinical Pathology Department, Tanta Cancer Center, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pathology Department, Tanta Cancer Center, Egypt","institution_ids":["https://openalex.org/I4405279817"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5063099905"],"corresponding_institution_ids":["https://openalex.org/I21376657"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":1.4005,"has_fulltext":true,"cited_by_count":22,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.78378528,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"27","issue":"1","first_page":"11","last_page":"18"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10337","display_name":"Liver Disease and Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/occult-hepatitis-b-infection","display_name":"occult hepatitis B infection","score":0.984000027179718},{"id":"https://openalex.org/keywords/hepatitis-b-reactivation","display_name":"HBV reactivation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/hbsag-negative-patients","display_name":"HBsAg-negative patients","score":0.878000020980835},{"id":"https://openalex.org/keywords/hbv-dna","display_name":"HBV DNA","score":0.7509999871253967},{"id":"https://openalex.org/keywords/lamivudine-prophylaxis","display_name":"lamivudine prophylaxis","score":0.9480000138282776},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9145938158035278},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.6826987266540527},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.6736817955970764},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5575578212738037},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.5005011558532715},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.4549320936203003},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4379739761352539},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4270135164260864},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4136062264442444},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38059911131858826},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3699888586997986},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.24618098139762878}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006509","descriptor_name":"Hepatitis B","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006514","descriptor_name":"Hepatitis B Surface Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014775","descriptor_name":"Virus Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016867","descriptor_name":"Immunocompromised Host","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jnci.2015.01.004","doi":"https://doi.org/10.1016/j.jnci.2015.01.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jnci.2015.01.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1110036215000060/pdf","source":{"id":"https://openalex.org/S4210209315","display_name":"Journal of the Egyptian National Cancer Institute","issn_l":"1110-0362","issn":["1110-0362","2589-0409"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Egyptian National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:25716703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25716703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Egyptian National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:da1f3bf4f944407c9c4be9d04d504a71","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/da1f3bf4f944407c9c4be9d04d504a71","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the Egyptian National Cancer Institute, Vol 27, Iss 1, Pp 11-18 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jnci.2015.01.004","doi":"https://doi.org/10.1016/j.jnci.2015.01.004","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jnci.2015.01.004","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1110036215000060/pdf","source":{"id":"https://openalex.org/S4210209315","display_name":"Journal of the Egyptian National Cancer Institute","issn_l":"1110-0362","issn":["1110-0362","2589-0409"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Egyptian National Cancer Institute","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016981968.pdf","grobid_xml":"https://content.openalex.org/works/W2016981968.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W101159551","https://openalex.org/W135571649","https://openalex.org/W1912693401","https://openalex.org/W1932939055","https://openalex.org/W1979792611","https://openalex.org/W1997047331","https://openalex.org/W2000635340","https://openalex.org/W2003808202","https://openalex.org/W2005790431","https://openalex.org/W2013054466","https://openalex.org/W2018071905","https://openalex.org/W2025722002","https://openalex.org/W2042507876","https://openalex.org/W2044997245","https://openalex.org/W2052815650","https://openalex.org/W2061199896","https://openalex.org/W2074505491","https://openalex.org/W2082477845","https://openalex.org/W2085997970","https://openalex.org/W2087727707","https://openalex.org/W2091884578","https://openalex.org/W2107315713","https://openalex.org/W2108827800","https://openalex.org/W2110809164","https://openalex.org/W2115919161","https://openalex.org/W2118082515","https://openalex.org/W2119526388","https://openalex.org/W2126145673","https://openalex.org/W2132387690","https://openalex.org/W2138955583","https://openalex.org/W2140846232","https://openalex.org/W2145905144","https://openalex.org/W2150587745","https://openalex.org/W2153665789","https://openalex.org/W2156015715","https://openalex.org/W2161758234","https://openalex.org/W2163208122","https://openalex.org/W2605539363","https://openalex.org/W3149727786","https://openalex.org/W4205736005"],"related_works":["https://openalex.org/W3013302761","https://openalex.org/W2466865404","https://openalex.org/W1708867766","https://openalex.org/W2082477845","https://openalex.org/W2161758234","https://openalex.org/W2007439575","https://openalex.org/W1964974008","https://openalex.org/W2549935498","https://openalex.org/W2976590113"],"abstract_inverted_index":{"BACKGROUND:":[0],"Occult":[1],"hepatitis":[2,10,17,29,77,121],"B":[3,11,18,30,78],"infection":[4],"(OBI)":[5],"is":[6,35,50,205,228],"characterized":[7],"by":[8],"negative":[9,81,116,178],"surface":[12,79],"antigen":[13,80],"(HBsAg)":[14],"and":[15,56,71,90,120,145],"detectable":[16],"virus":[19,123],"(HBV)-DNA":[20],"in":[21,45,53,60,173,192],"the":[22,36,69,93,151,187,221],"liver":[23],"and/or":[24],"serum,":[25],"with":[26,83,156],"or":[27],"without":[28],"core":[31],"antibody":[32],"(anti-HBc).":[33],"Anti-HBc":[34,170],"most":[37],"sensitive":[38],"marker":[39],"of":[40,74,95,101,143,153,175,186,217,224],"previous":[41],"HBV.":[42],"HBV":[43,58,218],"reactivation":[44,73,219],"patients":[46,82,89,102,115,134,191,210,233],"under":[47],"immunosuppressive":[48],"treatment":[49],"life-threatening,":[51],"occurring":[52],"both":[54],"overt":[55],"occult":[57],"especially":[59],"hematological":[61],"malignancies.":[62],"AIM":[63],"OF":[64],"THE":[65],"WORK:":[66],"To":[67],"evaluate":[68],"prevalence":[70],"chemotherapy-induced":[72],"OBI":[75,158,196],"among":[76,98],"diffuse":[84],"large":[85],"B-cell":[86],"lymphoma":[87],"(DLBCL)":[88],"to":[91,129],"determine":[92],"significance":[94],"anti-HBc":[96,189,203,231],"screening":[97,204],"this":[99,193],"group":[100],"before":[103,140,207,234],"receiving":[104],"chemotherapy.":[105,154,208,235],"PATIENTS":[106],"AND":[107],"METHODS:":[108],"This":[109],"cross-sectional":[110],"study":[111,194,200],"included":[112],"72":[113,176],"DLBCL":[114],"for":[117,147,161,215,230],"HBsAg,":[118],"HBsAb":[119],"C":[122],"antibodies":[124],"(anti-HCV).":[125],"Patients":[126,155],"were":[127,159],"subjected":[128],"investigations":[130],"including":[131],"anti-HBc.":[132],"All":[133],"underwent":[135],"alanine":[136],"transaminase":[137],"(ALT)":[138],"monitoring":[139,223],"each":[141],"cycle":[142],"chemotherapy":[144],"monthly":[146],"12":[148],"months":[149],"after":[150],"end":[152],"suspected":[157],"tested":[160],"HBV-DNA":[162],"using":[163],"real-time":[164],"polymerase":[165],"chain":[166],"reaction":[167],"(PCR).":[168],"RESULTS:":[169],"was":[171],"detected":[172],"10":[174,188],"HBsAg":[177],"sera":[179],"(13.89%)":[180],"(95%":[181],"confidence":[182],"interval":[183],"6.9-22.2%).":[184],"Five":[185],"positive":[190,232],"had":[195],"reactivation.":[197],"CONCLUSION:":[198],"The":[199],"concluded":[201],"that":[202],"mandatory":[206],"HBsAg-negative/anti-HBc-positive":[209],"should":[211],"be":[212],"closely":[213],"observed":[214],"signs":[216],"through":[220],"regular":[222],"ALT.":[225],"Prophylaxis":[226],"lamivudine":[227],"recommended":[229]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016981968","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
